-+ 0.00%
-+ 0.00%
-+ 0.00%

Evommune grants CEO $686,600 cash retention award

PUBT·11/17/2026 21:32:58
Listen to the news
Evommune grants CEO $686,600 cash retention award
  • Evommune repriced stock options covering 3,692,840 shares to $7.63 per share on November 13, 2026.
  • Original exercise prices ranged from $16 to $26.77; accessing the reduced price generally requires 12 months of continuous service.
  • Cash awards total $686,600 for CEO Luis Peña, $565,000 for CFO Kyle Carver and $595,000 for Chief Business & Legal Officer Gregory Moss.
  • Awards vest in equal installments on employment agreement amendments’ first two anniversaries, subject to continued employment; second installments also require stock-price conditions.
  • Second installments require a $15 closing price at the second anniversary or a 15-trading-day average of $15 during the preceding year.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Evommune Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-465600), on November 17, 2026, and is solely responsible for the information contained therein.